Nearly one in seven people who give birth experience postpartum depression.Right now, there's only one PPD medication, called brexanolone, currently approved by the FDA. While it's known to be extremely effective, access is very limited.But a revolution in treating perinatal and postpartum depression may be underway.We talk with experts about the current landscape of treatment for perinatal and postpartum depression and what FDA approval of a new medication, zuranolone could mean.Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Find us on Twitter @1A.